Event Details

This document appears to be page 100 of a financial research report produced by Cowen Collaborative Insights, dated February 25, 2019. It details valuation methodologies and investment risks specifically related to the U.S. and Canadian cannabis industries. The page bears a House Oversight Committee Bates stamp, suggesting it was part of a larger production of documents, likely related to financial investigations, though the text itself does not mention Jeffrey Epstein.